Dihydromirycetin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dihydromirycetin, covering 2023-05-23 to 2023-05-23. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus [Phase 2]